Effectiveness and Cost Effectiveness of Human Papillomavirus VaccineA Systematic Review

被引：0
|
作者：
Fawziah Marra
Karine Cloutier
Bridgette Oteng
Carlo Marra
Gina Ogilvie
机构：
[1] University of British Columbia,Faculty of Pharmaceutical Sciences
[2] British Columbia Centre for Disease Control,undefined
[3] University of Laval,undefined
[4] Centre for Health Evaluation and Outcomes Sciences,undefined
[5] University of British Columbia BC Centre for Disease Control,undefined
来源：
PharmacoEconomics | 2009年 / 27卷
关键词：
Cervical Cancer; Cervical Intraepithelial Neoplasia; Vaccine Efficacy; Genital Wart; Invasive Cervical Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The recent approval of human papillomavirus (HPV) vaccine means that decision makers need information beyond that available from randomized clinical trials to recommend funding for this vaccination programme. Modelling and economic studies have addressed some of those information needs. We conducted a qualitative systematic review to summarize the existing data. Review articles were obtained from an extensive literature search on studies using mathematical modelling (either a Markov or transmission dynamic model) to determine the effectiveness or cost effectiveness of an HPV vaccine compared with the current cytology-based Pap smear screening programme.
引用
收藏
页码：127 / 147
页数：20
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    Habbema, J. Dik F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (15): : 1083 - 1092
  • [32] Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany
    Hillemanns P.
    Petry K.U.
    Largeron N.
    McAllister R.
    Tolley K.
    Büsch K.
    Journal of Public Health, 2009, 17 (2) : 77 - 86
  • [33] The Cost-Effectiveness of a Quadrivalent Human Papillomavirus Vaccine in Taiwan
    Dasbach, Erik J.
    Insinga, Ralph P.
    Yang, Yuh Cheng
    Pwu, Raoh-Fang
    Lac, Christina
    Elbasha, Elamin H.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (03) : 459 - 466
  • [34] Cost-effectiveness of different human papillomavirus vaccines in Singapore
    Vernon J Lee
    Sun Kuie Tay
    Yee Leong Teoh
    Mei Yin Tok
    BMC Public Health, 11
  • [35] The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Hungary
    Dasbach, E.
    Elbasha, E.
    Insinga, R.
    Nagy, L.
    VALUE IN HEALTH, 2007, 10 (06) : A443 - A443
  • [36] Cost-effectiveness of human papillomavirus vaccination in the United States
    Chesson, Harrell W.
    Ekwueme, Donatus U.
    Saraiya, Mona
    Markowitz, Lauri E.
    EMERGING INFECTIOUS DISEASES, 2008, 14 (02) : 244 - 251
  • [37] Cost-effectiveness of human papillomavirus vaccination and screening in Spain
    Diaz, Mireia
    de Sanjose, Silvia
    Ortendahl, Jesse
    O'Shea, Meredith
    Goldie, Sue J.
    Bosch, F. Xavier
    Kim, Jane J.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2973 - 2985
  • [38] COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINE IN COLOMBIA IN 2007
    de la Hoz, F.
    Alvis, N.
    Narvaez, J.
    Gamboa, O.
    Choconta, A.
    VALUE IN HEALTH, 2009, 12 (03) : A42 - A42
  • [39] Cost-effectiveness of different human papillomavirus vaccines in Singapore
    Lee, Vernon J.
    Tay, Sun Kuie
    Teoh, Yee Leong
    Tok, Mei Yin
    BMC PUBLIC HEALTH, 2011, 11
  • [40] Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis
    Tejada, Romina A.
    Malagon, Talia
    Franco, Eduardo L.
    VACCINE, 2022, 40 (19) : 2667 - 2678
12345